

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | proline biosynthetic process (GO:0006561) | 5.83401272 |
| 2 | regulation of integrin activation (GO:0033623) | 5.04792670 |
| 3 | positive regulation by symbiont of host defense response (GO:0052509) | 4.58745733 |
| 4 | modulation by symbiont of host defense response (GO:0052031) | 4.58745733 |
| 5 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.58745733 |
| 6 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.58745733 |
| 7 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.58745733 |
| 8 | modulation by symbiont of host immune response (GO:0052553) | 4.58745733 |
| 9 | embryonic process involved in female pregnancy (GO:0060136) | 4.56938720 |
| 10 | proline metabolic process (GO:0006560) | 4.24344870 |
| 11 | transcription from mitochondrial promoter (GO:0006390) | 4.06681680 |
| 12 | negative regulation of cell killing (GO:0031342) | 3.99590647 |
| 13 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.99590647 |
| 14 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.94934123 |
| 15 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 3.85480010 |
| 16 | detection of molecule of bacterial origin (GO:0032490) | 3.84378941 |
| 17 | regulation of hippo signaling (GO:0035330) | 3.84088016 |
| 18 | neutrophil activation involved in immune response (GO:0002283) | 3.83917918 |
| 19 | sarcomere organization (GO:0045214) | 3.83114565 |
| 20 | regulation of translational fidelity (GO:0006450) | 3.82205205 |
| 21 | response to peptidoglycan (GO:0032494) | 3.82031513 |
| 22 | establishment of apical/basal cell polarity (GO:0035089) | 3.81489879 |
| 23 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.78747144 |
| 24 | macrophage activation involved in immune response (GO:0002281) | 3.71727155 |
| 25 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 3.71009636 |
| 26 | mitotic G1 DNA damage checkpoint (GO:0031571) | 3.66590592 |
| 27 | plasma membrane repair (GO:0001778) | 3.63962049 |
| 28 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.61203811 |
| 29 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.61084816 |
| 30 | apoptotic process involved in morphogenesis (GO:0060561) | 3.60852460 |
| 31 | embryonic placenta development (GO:0001892) | 3.58076472 |
| 32 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.53613043 |
| 33 | detection of other organism (GO:0098543) | 3.52817477 |
| 34 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.46593467 |
| 35 | regulation of tight junction assembly (GO:2000810) | 3.44111313 |
| 36 | detection of external biotic stimulus (GO:0098581) | 3.41001709 |
| 37 | carnitine shuttle (GO:0006853) | 3.40832323 |
| 38 | cardiac myofibril assembly (GO:0055003) | 3.37740150 |
| 39 | epithelial cell-cell adhesion (GO:0090136) | 3.33931232 |
| 40 | lysine metabolic process (GO:0006553) | 3.29295347 |
| 41 | lysine catabolic process (GO:0006554) | 3.29295347 |
| 42 | detection of bacterium (GO:0016045) | 3.26022104 |
| 43 | apoptotic cell clearance (GO:0043277) | 3.20639787 |
| 44 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 3.20107094 |
| 45 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.19143545 |
| 46 | fatty acid transmembrane transport (GO:1902001) | 3.18424338 |
| 47 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.14436991 |
| 48 | response to host (GO:0075136) | 3.14436991 |
| 49 | response to host defenses (GO:0052200) | 3.14436991 |
| 50 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 3.14332036 |
| 51 | barbed-end actin filament capping (GO:0051016) | 3.11027394 |
| 52 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 3.10004583 |
| 53 | regulation of leukocyte degranulation (GO:0043300) | 3.09937703 |
| 54 | mitotic G1/S transition checkpoint (GO:0044819) | 3.09690753 |
| 55 | cardiac muscle cell development (GO:0055013) | 3.09050378 |
| 56 | response to host immune response (GO:0052572) | 3.06717149 |
| 57 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.06717149 |
| 58 | cellular extravasation (GO:0045123) | 3.06082313 |
| 59 | negative regulation of interleukin-12 production (GO:0032695) | 3.04386398 |
| 60 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.04250919 |
| 61 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.03137563 |
| 62 | stress fiber assembly (GO:0043149) | 3.01295951 |
| 63 | positive regulation of protein homooligomerization (GO:0032464) | 3.00698312 |
| 64 | mitochondrial DNA metabolic process (GO:0032042) | 3.00466960 |
| 65 | pinocytosis (GO:0006907) | 3.00454251 |
| 66 | response to muramyl dipeptide (GO:0032495) | 2.98929472 |
| 67 | hypotonic response (GO:0006971) | 2.98574369 |
| 68 | establishment of monopolar cell polarity (GO:0061162) | 2.98563592 |
| 69 | establishment or maintenance of monopolar cell polarity (GO:0061339) | 2.98563592 |
| 70 | regulation of mast cell degranulation (GO:0043304) | 2.97784773 |
| 71 | tricarboxylic acid cycle (GO:0006099) | 2.97770053 |
| 72 | detection of biotic stimulus (GO:0009595) | 2.97356203 |
| 73 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.96197274 |
| 74 | regulation of cholesterol homeostasis (GO:2000188) | 2.93647261 |
| 75 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.93525315 |
| 76 | 4-hydroxyproline metabolic process (GO:0019471) | 2.91062542 |
| 77 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.91009269 |
| 78 | cardiac cell development (GO:0055006) | 2.90135221 |
| 79 | peptidyl-proline hydroxylation (GO:0019511) | 2.89701299 |
| 80 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.88783965 |
| 81 | negative regulation of fatty acid metabolic process (GO:0045922) | 2.87028835 |
| 82 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 2.86945838 |
| 83 | G1 DNA damage checkpoint (GO:0044783) | 2.86761650 |
| 84 | regulation of protein homooligomerization (GO:0032462) | 2.86234551 |
| 85 | protein hydroxylation (GO:0018126) | 2.83684005 |
| 86 | embryonic camera-type eye development (GO:0031076) | 2.80883899 |
| 87 | sulfur amino acid catabolic process (GO:0000098) | 2.80856468 |
| 88 | response to laminar fluid shear stress (GO:0034616) | 2.80290702 |
| 89 | COPI coating of Golgi vesicle (GO:0048205) | 2.79441483 |
| 90 | Golgi transport vesicle coating (GO:0048200) | 2.79441483 |
| 91 | germinal center formation (GO:0002467) | 2.77946571 |
| 92 | positive regulation of receptor recycling (GO:0001921) | 2.77921035 |
| 93 | replication fork processing (GO:0031297) | 2.77134835 |
| 94 | trophectodermal cell differentiation (GO:0001829) | 2.76494908 |
| 95 | cell-substrate junction assembly (GO:0007044) | 2.76128236 |
| 96 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.75181809 |
| 97 | regulation of integrin-mediated signaling pathway (GO:2001044) | 2.74265870 |
| 98 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.73366669 |
| 99 | regulation of gamma-delta T cell activation (GO:0046643) | 2.72045124 |
| 100 | regulation of early endosome to late endosome transport (GO:2000641) | 2.70280342 |
| 101 | positive regulation of protein oligomerization (GO:0032461) | 2.68970623 |
| 102 | 2-oxoglutarate metabolic process (GO:0006103) | 2.67844601 |
| 103 | macrophage activation (GO:0042116) | 2.67261345 |
| 104 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.66673288 |
| 105 | neutrophil activation (GO:0042119) | 2.66459769 |
| 106 | * protein localization to endosome (GO:0036010) | 2.66417812 |
| 107 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.65742204 |
| 108 | cellular response to zinc ion (GO:0071294) | 2.65540007 |
| 109 | actomyosin structure organization (GO:0031032) | 2.64236272 |
| 110 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.63995454 |
| 111 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.63121055 |
| 112 | immunoglobulin mediated immune response (GO:0016064) | 2.63084171 |
| 113 | myofibril assembly (GO:0030239) | 2.61230187 |
| 114 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.60936569 |
| 115 | oxidative demethylation (GO:0070989) | 2.60828329 |
| 116 | basement membrane organization (GO:0071711) | 2.60647923 |
| 117 | respiratory burst (GO:0045730) | 2.60386503 |
| 118 | protein retention in ER lumen (GO:0006621) | 2.60121570 |
| 119 | amino-acid betaine transport (GO:0015838) | 2.59429354 |
| 120 | carnitine transport (GO:0015879) | 2.59429354 |
| 121 | mannose metabolic process (GO:0006013) | 2.59389219 |
| 122 | granulocyte activation (GO:0036230) | 2.58972189 |
| 123 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.58667663 |
| 124 | adherens junction assembly (GO:0034333) | 2.56521303 |
| 125 | fibroblast migration (GO:0010761) | 2.56285518 |
| 126 | regulation of necroptotic process (GO:0060544) | 2.55611014 |
| 127 | carnitine transmembrane transport (GO:1902603) | 2.55126409 |
| 128 | actin-myosin filament sliding (GO:0033275) | 2.54573366 |
| 129 | muscle filament sliding (GO:0030049) | 2.54573366 |
| 130 | positive regulation of SMAD protein import into nucleus (GO:0060391) | 2.54167474 |
| 131 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.53306782 |
| 132 | maternal placenta development (GO:0001893) | 2.53065931 |
| 133 | positive regulation of leukocyte degranulation (GO:0043302) | 2.52851855 |
| 134 | regulation of macrophage cytokine production (GO:0010935) | 2.51640448 |
| 135 | regulation of sister chromatid cohesion (GO:0007063) | 2.50816504 |
| 136 | glutamine family amino acid biosynthetic process (GO:0009084) | 2.48269115 |
| 137 | regulation of regulated secretory pathway (GO:1903305) | 2.47881575 |
| 138 | apoptotic process involved in development (GO:1902742) | 2.46940562 |
| 139 | aspartate family amino acid catabolic process (GO:0009068) | 2.46570397 |
| 140 | low-density lipoprotein particle clearance (GO:0034383) | 2.45943009 |
| 141 | cell adhesion mediated by integrin (GO:0033627) | 2.45852525 |
| 142 | positive regulation of p38MAPK cascade (GO:1900745) | 2.45682578 |
| 143 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.45252969 |
| 144 | myeloid cell activation involved in immune response (GO:0002275) | 2.45157153 |
| 145 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.44998960 |
| 146 | positive regulation of mitotic metaphase/anaphase transition (GO:0045842) | 2.43921692 |
| 147 | positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101) | 2.43921692 |
| 148 | positive regulation of mitotic sister chromatid separation (GO:1901970) | 2.43921692 |
| 149 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.43255022 |
| 150 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.42364734 |
| 151 | positive regulation of myotube differentiation (GO:0010831) | 2.41836220 |
| 152 | activation of Rac GTPase activity (GO:0032863) | 2.41167414 |
| 153 | negative regulation of chondrocyte differentiation (GO:0032331) | 2.40910130 |
| 154 | negative regulation of cardiac muscle tissue growth (GO:0055022) | 2.39961217 |
| 155 | negative regulation of heart growth (GO:0061117) | 2.39961217 |
| 156 | labyrinthine layer development (GO:0060711) | 2.39897173 |
| 157 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.39730585 |
| 158 | regulation of SMAD protein import into nucleus (GO:0060390) | 2.39694705 |
| 159 | pentose-phosphate shunt (GO:0006098) | 2.39592481 |
| 160 | hemidesmosome assembly (GO:0031581) | 2.38968319 |
| 161 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.38445630 |
| 162 | anatomical structure regression (GO:0060033) | 2.37803202 |
| 163 | regulation of superoxide anion generation (GO:0032928) | 2.37524679 |
| 164 | negative regulation of cell size (GO:0045792) | 2.36536886 |
| 165 | positive regulation of mast cell activation (GO:0033005) | 2.36524527 |
| 166 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.36183190 |
| 167 | regulation of podosome assembly (GO:0071801) | 2.36009950 |
| 168 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.35814642 |
| 169 | cell-substrate adherens junction assembly (GO:0007045) | 2.35388497 |
| 170 | focal adhesion assembly (GO:0048041) | 2.35388497 |
| 171 | peptide catabolic process (GO:0043171) | 2.34757136 |
| 172 | regulation of macrophage chemotaxis (GO:0010758) | 2.33961991 |
| 173 | mitochondrial fusion (GO:0008053) | 2.33897626 |
| 174 | fatty acid beta-oxidation (GO:0006635) | 2.33654462 |
| 175 | microglial cell activation (GO:0001774) | 2.33442616 |
| 176 | substrate adhesion-dependent cell spreading (GO:0034446) | 2.32867198 |
| 177 | paraxial mesoderm development (GO:0048339) | 2.32519201 |
| 178 | endodermal cell differentiation (GO:0035987) | 2.32338557 |
| 179 | modulation by symbiont of host cellular process (GO:0044068) | 2.32245209 |
| 180 | response to thyroid hormone (GO:0097066) | 2.32231134 |
| 181 | positive regulation of lamellipodium assembly (GO:0010592) | 2.32120317 |
| 182 | leukocyte aggregation (GO:0070486) | 2.31634819 |
| 183 | cellular response to type I interferon (GO:0071357) | 2.26259484 |
| 184 | type I interferon signaling pathway (GO:0060337) | 2.26259484 |
| 185 | negative regulation of protein localization to plasma membrane (GO:1903077) | 2.25570972 |
| 186 | positive regulation of macrophage cytokine production (GO:0060907) | 2.25005286 |
| 187 | response to type I interferon (GO:0034340) | 2.24776024 |
| 188 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.24225961 |
| 189 | NIK/NF-kappaB signaling (GO:0038061) | 2.23734642 |
| 190 | glycosphingolipid catabolic process (GO:0046479) | 2.23602761 |
| 191 | B cell receptor signaling pathway (GO:0050853) | 2.22238106 |
| 192 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.21273465 |
| 193 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.20460555 |
| 194 | negative regulation of necroptotic process (GO:0060546) | 2.19675537 |
| 195 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.19600588 |
| 196 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.17483980 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.98473132 |
| 2 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.61739874 |
| 3 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.47314953 |
| 4 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.43157097 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.34665470 |
| 6 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.31726812 |
| 7 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.31016638 |
| 8 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 2.28752628 |
| 9 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.28328475 |
| 10 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.23280679 |
| 11 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.17375871 |
| 12 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.10969853 |
| 13 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.08651282 |
| 14 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.05390525 |
| 15 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.03966475 |
| 16 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.03740560 |
| 17 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.02829483 |
| 18 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.94698004 |
| 19 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.94048281 |
| 20 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.93401101 |
| 21 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.90776448 |
| 22 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.90493467 |
| 23 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.87778894 |
| 24 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.86587133 |
| 25 | SPI1_23127762_ChIP-Seq_K562_Human | 1.85125593 |
| 26 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.84458488 |
| 27 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.84417815 |
| 28 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.84281401 |
| 29 | MYC_22102868_ChIP-Seq_BL_Human | 1.83746930 |
| 30 | ATF3_27146783_Chip-Seq_COLON_Human | 1.81484822 |
| 31 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.78260917 |
| 32 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.77301154 |
| 33 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.76776353 |
| 34 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.75542377 |
| 35 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.73811412 |
| 36 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.70656036 |
| 37 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.69368437 |
| 38 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.67769472 |
| 39 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.65115172 |
| 40 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.63665321 |
| 41 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.63417276 |
| 42 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.62801290 |
| 43 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.62786685 |
| 44 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.62678039 |
| 45 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.62215568 |
| 46 | * RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.62180751 |
| 47 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.61896796 |
| 48 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.61167759 |
| 49 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.59795709 |
| 50 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.59660465 |
| 51 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.59377138 |
| 52 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.59268752 |
| 53 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.58584317 |
| 54 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.56731853 |
| 55 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.55059534 |
| 56 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.54944855 |
| 57 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.51299422 |
| 58 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.51235733 |
| 59 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.49767190 |
| 60 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.49039383 |
| 61 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.48927205 |
| 62 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.48577791 |
| 63 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.47764293 |
| 64 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.46647162 |
| 65 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.45689738 |
| 66 | UTX_26944678_Chip-Seq_JUKART_Human | 1.44536098 |
| 67 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.43251817 |
| 68 | GATA1_19941826_ChIP-Seq_K562_Human | 1.42898439 |
| 69 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.42597032 |
| 70 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.41605928 |
| 71 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.41494483 |
| 72 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.40394378 |
| 73 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.39700285 |
| 74 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.38954112 |
| 75 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.38954112 |
| 76 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.37262868 |
| 77 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.35235914 |
| 78 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.33777559 |
| 79 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.33608566 |
| 80 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.32948482 |
| 81 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.31592296 |
| 82 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.28718238 |
| 83 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.28113411 |
| 84 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.26245238 |
| 85 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.25973418 |
| 86 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.25750588 |
| 87 | * GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.25525842 |
| 88 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.23989575 |
| 89 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.23960242 |
| 90 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.21301765 |
| 91 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.21269556 |
| 92 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.20963466 |
| 93 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.19148933 |
| 94 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.18767004 |
| 95 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.18547993 |
| 96 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 1.17636905 |
| 97 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.17621834 |
| 98 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.17582082 |
| 99 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.17252286 |
| 100 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.16849000 |
| 101 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.16718578 |
| 102 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.16591886 |
| 103 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.15205444 |
| 104 | MAF_26560356_Chip-Seq_TH2_Human | 1.14681197 |
| 105 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.14381276 |
| 106 | * NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.14332872 |
| 107 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.12801526 |
| 108 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.12029973 |
| 109 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.11579984 |
| 110 | * ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.09443565 |
| 111 | * GATA2_19941826_ChIP-Seq_K562_Human | 1.07627358 |
| 112 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.07301884 |
| 113 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.06927824 |
| 114 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.06411270 |
| 115 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.06019927 |
| 116 | * RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.05900947 |
| 117 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 1.05346209 |
| 118 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.05323804 |
| 119 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.05268063 |
| 120 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.05220223 |
| 121 | MYB_26560356_Chip-Seq_TH1_Human | 1.04869431 |
| 122 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.04743879 |
| 123 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.03714416 |
| 124 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.02983339 |
| 125 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.02966022 |
| 126 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.01618404 |
| 127 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.00895332 |
| 128 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.00242006 |
| 129 | POU5F1_16518401_ChIP-PET_MESCs_Mouse | 1.00026581 |
| 130 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 0.99965437 |
| 131 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.98917277 |
| 132 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.98423420 |
| 133 | * KDM2B_26808549_Chip-Seq_K562_Human | 0.98033723 |
| 134 | MAF_26560356_Chip-Seq_TH1_Human | 0.97900550 |
| 135 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.97765947 |
| 136 | * ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.97708395 |
| 137 | TCF3_18692474_ChIP-Seq_MESCs_Mouse | 0.97264070 |
| 138 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.96044088 |
| 139 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.95713328 |
| 140 | NANOG_18347094_ChIP-ChIP_MESCs_Mouse | 0.95547682 |
| 141 | P68_20966046_ChIP-Seq_HELA_Human | 0.95466921 |
| 142 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.94238497 |
| 143 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.93287698 |
| 144 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.93266596 |
| 145 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.92755623 |
| 146 | * CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.92750348 |
| 147 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 0.92132356 |
| 148 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.91824929 |
| 149 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.90724608 |
| 150 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.90303628 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003705_abnormal_hypodermis_morpholog | 3.54858266 |
| 2 | MP0003303_peritoneal_inflammation | 3.22872196 |
| 3 | MP0003436_decreased_susceptibility_to | 3.08522998 |
| 4 | MP0005451_abnormal_body_composition | 2.95960991 |
| 5 | MP0003724_increased_susceptibility_to | 2.88763867 |
| 6 | MP0008260_abnormal_autophagy | 2.67034184 |
| 7 | MP0000751_myopathy | 2.65128656 |
| 8 | MP0004233_abnormal_muscle_weight | 2.61675585 |
| 9 | MP0004084_abnormal_cardiac_muscle | 2.52815128 |
| 10 | MP0005464_abnormal_platelet_physiology | 2.37900626 |
| 11 | MP0003566_abnormal_cell_adhesion | 2.37637710 |
| 12 | MP0009278_abnormal_bone_marrow | 2.35852588 |
| 13 | MP0010352_gastrointestinal_tract_polyps | 2.33884169 |
| 14 | MP0003646_muscle_fatigue | 2.23735545 |
| 15 | MP0002419_abnormal_innate_immunity | 2.22471311 |
| 16 | MP0005330_cardiomyopathy | 2.05250701 |
| 17 | MP0001835_abnormal_antigen_presentation | 2.00603287 |
| 18 | MP0002837_dystrophic_cardiac_calcinosis | 1.99556273 |
| 19 | MP0000685_abnormal_immune_system | 1.96180346 |
| 20 | MP0004087_abnormal_muscle_fiber | 1.92709206 |
| 21 | MP0002269_muscular_atrophy | 1.91800748 |
| 22 | MP0004947_skin_inflammation | 1.88357807 |
| 23 | MP0000858_altered_metastatic_potential | 1.87882922 |
| 24 | MP0005025_abnormal_response_to | 1.86412776 |
| 25 | MP0008438_abnormal_cutaneous_collagen | 1.81730203 |
| 26 | MP0010630_abnormal_cardiac_muscle | 1.80098653 |
| 27 | MP0000749_muscle_degeneration | 1.79028237 |
| 28 | MP0010234_abnormal_vibrissa_follicle | 1.78558948 |
| 29 | MP0010030_abnormal_orbit_morphology | 1.72990742 |
| 30 | MP0005000_abnormal_immune_tolerance | 1.70262480 |
| 31 | MP0001533_abnormal_skeleton_physiology | 1.67895951 |
| 32 | MP0001790_abnormal_immune_system | 1.66883573 |
| 33 | MP0005387_immune_system_phenotype | 1.66883573 |
| 34 | MP0000750_abnormal_muscle_regeneration | 1.65072328 |
| 35 | MP0005076_abnormal_cell_differentiation | 1.64366266 |
| 36 | MP0003828_pulmonary_edema | 1.63020210 |
| 37 | MP0002998_abnormal_bone_remodeling | 1.60297920 |
| 38 | MP0005023_abnormal_wound_healing | 1.60175203 |
| 39 | MP0009785_altered_susceptibility_to | 1.57698469 |
| 40 | MP0008775_abnormal_heart_ventricle | 1.56860837 |
| 41 | MP0004185_abnormal_adipocyte_glucose | 1.56234252 |
| 42 | MP0002452_abnormal_antigen_presenting | 1.53740597 |
| 43 | MP0003279_aneurysm | 1.53115982 |
| 44 | MP0006082_CNS_inflammation | 1.51115184 |
| 45 | MP0003183_abnormal_peptide_metabolism | 1.49044301 |
| 46 | MP0001800_abnormal_humoral_immune | 1.48505858 |
| 47 | MP0009840_abnormal_foam_cell | 1.48038119 |
| 48 | MP0002723_abnormal_immune_serum | 1.46416191 |
| 49 | MP0010155_abnormal_intestine_physiology | 1.45402796 |
| 50 | MP0003075_altered_response_to | 1.44523321 |
| 51 | MP0002877_abnormal_melanocyte_morpholog | 1.43730345 |
| 52 | MP0002420_abnormal_adaptive_immunity | 1.43671571 |
| 53 | MP0001819_abnormal_immune_cell | 1.43131875 |
| 54 | MP0001545_abnormal_hematopoietic_system | 1.42260998 |
| 55 | MP0005397_hematopoietic_system_phenotyp | 1.42260998 |
| 56 | MP0004858_abnormal_nervous_system | 1.42178404 |
| 57 | MP0005360_urolithiasis | 1.41281429 |
| 58 | MP0002148_abnormal_hypersensitivity_rea | 1.41264549 |
| 59 | MP0005409_darkened_coat_color | 1.39934662 |
| 60 | MP0004510_myositis | 1.37573659 |
| 61 | MP0008057_abnormal_DNA_replication | 1.37441527 |
| 62 | MP0005058_abnormal_lysosome_morphology | 1.37250379 |
| 63 | MP0000733_abnormal_muscle_development | 1.36312511 |
| 64 | MP0004130_abnormal_muscle_cell | 1.35692889 |
| 65 | MP0004036_abnormal_muscle_relaxation | 1.30583727 |
| 66 | MP0004215_abnormal_myocardial_fiber | 1.30565612 |
| 67 | MP0003453_abnormal_keratinocyte_physiol | 1.29791976 |
| 68 | MP0002405_respiratory_system_inflammati | 1.28563337 |
| 69 | MP0005671_abnormal_response_to | 1.28214817 |
| 70 | MP0000604_amyloidosis | 1.26436432 |
| 71 | MP0003329_amyloid_beta_deposits | 1.25037594 |
| 72 | MP0003191_abnormal_cellular_cholesterol | 1.24710511 |
| 73 | MP0005085_abnormal_gallbladder_physiolo | 1.24397074 |
| 74 | MP0003091_abnormal_cell_migration | 1.24121066 |
| 75 | MP0003950_abnormal_plasma_membrane | 1.23427530 |
| 76 | MP0005365_abnormal_bile_salt | 1.21019506 |
| 77 | MP0005666_abnormal_adipose_tissue | 1.20867274 |
| 78 | MP0000465_gastrointestinal_hemorrhage | 1.20591851 |
| 79 | MP0001845_abnormal_inflammatory_respons | 1.19602673 |
| 80 | MP0001544_abnormal_cardiovascular_syste | 1.18714494 |
| 81 | MP0005385_cardiovascular_system_phenoty | 1.18714494 |
| 82 | MP0003656_abnormal_erythrocyte_physiolo | 1.18393846 |
| 83 | MP0002106_abnormal_muscle_physiology | 1.16979359 |
| 84 | MP0006138_congestive_heart_failure | 1.16274027 |
| 85 | MP0002086_abnormal_extraembryonic_tissu | 1.16247192 |
| 86 | MP0010368_abnormal_lymphatic_system | 1.15638690 |
| 87 | MP0003045_fibrosis | 1.14981598 |
| 88 | MP0001851_eye_inflammation | 1.13481032 |
| 89 | MP0000747_muscle_weakness | 1.12400878 |
| 90 | MP0002398_abnormal_bone_marrow | 1.12350399 |
| 91 | MP0005623_abnormal_meninges_morphology | 1.10770989 |
| 92 | MP0003806_abnormal_nucleotide_metabolis | 1.10571578 |
| 93 | MP0001915_intracranial_hemorrhage | 1.10564668 |
| 94 | MP0000759_abnormal_skeletal_muscle | 1.10455089 |
| 95 | MP0003763_abnormal_thymus_physiology | 1.08903383 |
| 96 | MP0002972_abnormal_cardiac_muscle | 1.08538352 |
| 97 | MP0005164_abnormal_response_to | 1.08152911 |
| 98 | MP0000716_abnormal_immune_system | 1.07803382 |
| 99 | MP0003567_abnormal_fetal_cardiomyocyte | 1.06476339 |
| 100 | MP0003448_altered_tumor_morphology | 1.05776223 |
| 101 | MP0004272_abnormal_basement_membrane | 1.05626627 |
| 102 | MP0003984_embryonic_growth_retardation | 1.05448084 |
| 103 | MP0004264_abnormal_extraembryonic_tissu | 1.04973381 |
| 104 | MP0000343_altered_response_to | 1.04014145 |
| 105 | MP0005166_decreased_susceptibility_to | 1.02724818 |
| 106 | MP0010307_abnormal_tumor_latency | 1.02018254 |
| 107 | MP0002088_abnormal_embryonic_growth/wei | 1.01893925 |
| 108 | MP0001958_emphysema | 1.01667938 |
| 109 | MP0009333_abnormal_splenocyte_physiolog | 1.01655459 |
| 110 | MP0005380_embryogenesis_phenotype | 1.01032294 |
| 111 | MP0001672_abnormal_embryogenesis/_devel | 1.01032294 |
| 112 | MP0003866_abnormal_defecation | 1.00973921 |
| 113 | MP0002132_abnormal_respiratory_system | 1.00850556 |
| 114 | MP0001697_abnormal_embryo_size | 1.00527928 |
| 115 | MP0008469_abnormal_protein_level | 0.99938115 |
| 116 | MP0002332_abnormal_exercise_endurance | 0.99707426 |
| 117 | MP0004381_abnormal_hair_follicle | 0.99463455 |
| 118 | MP0002139_abnormal_hepatobiliary_system | 0.99170106 |
| 119 | MP0004883_abnormal_blood_vessel | 0.99160391 |
| 120 | MP0008004_abnormal_stomach_pH | 0.98761114 |
| 121 | MP0005257_abnormal_intraocular_pressure | 0.97872629 |
| 122 | MP0005310_abnormal_salivary_gland | 0.97025247 |
| 123 | MP0002166_altered_tumor_susceptibility | 0.96677109 |
| 124 | MP0000767_abnormal_smooth_muscle | 0.96534419 |
| 125 | MP0000266_abnormal_heart_morphology | 0.96294447 |
| 126 | MP0002429_abnormal_blood_cell | 0.95730232 |
| 127 | MP0004197_abnormal_fetal_growth/weight/ | 0.95360899 |
| 128 | MP0003252_abnormal_bile_duct | 0.94801139 |
| 129 | MP0003221_abnormal_cardiomyocyte_apopto | 0.94453687 |
| 130 | MP0002722_abnormal_immune_system | 0.93702049 |
| 131 | MP0003283_abnormal_digestive_organ | 0.93059530 |
| 132 | MP0001730_embryonic_growth_arrest | 0.91855588 |
| 133 | MP0004808_abnormal_hematopoietic_stem | 0.91654769 |
| 134 | MP0005369_muscle_phenotype | 0.90703708 |
| 135 | MP0000015_abnormal_ear_pigmentation | 0.89649958 |
| 136 | MP0001853_heart_inflammation | 0.89481363 |
| 137 | MP0002084_abnormal_developmental_patter | 0.88464082 |
| 138 | MP0005620_abnormal_muscle_contractility | 0.88308867 |
| 139 | MP0003690_abnormal_glial_cell | 0.88092727 |
| 140 | MP0005275_abnormal_skin_tensile | 0.88054143 |
| 141 | MP0002060_abnormal_skin_morphology | 0.87827424 |
| 142 | MP0003137_abnormal_impulse_conducting | 0.86656732 |
| 143 | MP0005083_abnormal_biliary_tract | 0.86489101 |
| 144 | MP0005319_abnormal_enzyme/_coenzyme | 0.86096620 |
| 145 | MP0002925_abnormal_cardiovascular_devel | 0.85317096 |
| 146 | MP0000689_abnormal_spleen_morphology | 0.84340326 |
| 147 | MP0002282_abnormal_trachea_morphology | 0.84039117 |
| 148 | MP0003300_gastrointestinal_ulcer | 0.83988332 |
| 149 | MP0003172_abnormal_lysosome_physiology | 0.83429490 |
| 150 | MP0002396_abnormal_hematopoietic_system | 0.82994371 |
| 151 | MP0004957_abnormal_blastocyst_morpholog | 0.81614879 |
| 152 | MP0005621_abnormal_cell_physiology | 0.81257477 |
| 153 | MP0002128_abnormal_blood_circulation | 0.81124518 |
| 154 | MP0000350_abnormal_cell_proliferation | 0.80556168 |
| 155 | MP0009115_abnormal_fat_cell | 0.80205851 |
| 156 | MP0003795_abnormal_bone_structure | 0.79345242 |
| 157 | MP0005165_increased_susceptibility_to | 0.79184252 |
| 158 | MP0002085_abnormal_embryonic_tissue | 0.79159172 |
| 159 | MP0005266_abnormal_metabolism | 0.79039056 |
| 160 | MP0002168_other_aberrant_phenotype | 0.78048563 |
| 161 | MP0002653_abnormal_ependyma_morphology | 0.78014630 |
| 162 | MP0009384_cardiac_valve_regurgitation | 0.77922362 |
| 163 | MP0005375_adipose_tissue_phenotype | 0.77829161 |
| 164 | MP0005670_abnormal_white_adipose | 0.77303475 |
| 165 | MP0000249_abnormal_blood_vessel | 0.76857101 |
| 166 | MP0001849_ear_inflammation | 0.75179964 |
| 167 | MP0009764_decreased_sensitivity_to | 0.74897733 |
| 168 | MP0009763_increased_sensitivity_to | 0.74065767 |
| 169 | MP0005390_skeleton_phenotype | 0.73424383 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 4.48591076 |
| 2 | Cerebral aneurysm (HP:0004944) | 4.00078287 |
| 3 | Right ventricular cardiomyopathy (HP:0011663) | 3.96838877 |
| 4 | Increased connective tissue (HP:0009025) | 3.90339284 |
| 5 | Abnormality of macrophages (HP:0004311) | 3.79845643 |
| 6 | Recurrent abscess formation (HP:0002722) | 3.52280739 |
| 7 | Ulnar bowing (HP:0003031) | 3.47138909 |
| 8 | Ventricular tachycardia (HP:0004756) | 3.43818117 |
| 9 | Muscle fiber splitting (HP:0003555) | 3.37188862 |
| 10 | Recurrent bacterial skin infections (HP:0005406) | 3.33640095 |
| 11 | Alopecia of scalp (HP:0002293) | 3.26734297 |
| 12 | Asymmetric septal hypertrophy (HP:0001670) | 3.25055712 |
| 13 | Difficulty climbing stairs (HP:0003551) | 3.22213304 |
| 14 | Protrusio acetabuli (HP:0003179) | 3.09292481 |
| 15 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.09195759 |
| 16 | Sudden death (HP:0001699) | 3.06418576 |
| 17 | Polycythemia (HP:0001901) | 2.97108929 |
| 18 | Hyporeflexia of lower limbs (HP:0002600) | 2.94607887 |
| 19 | Hypoplastic ischia (HP:0003175) | 2.87954801 |
| 20 | Flat acetabular roof (HP:0003180) | 2.85581231 |
| 21 | Abnormality of glycolipid metabolism (HP:0010969) | 2.81615033 |
| 22 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.81615033 |
| 23 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.81615033 |
| 24 | Myositis (HP:0100614) | 2.80620073 |
| 25 | Orchitis (HP:0100796) | 2.78194769 |
| 26 | Cellulitis (HP:0100658) | 2.64807448 |
| 27 | Spontaneous hematomas (HP:0007420) | 2.63982619 |
| 28 | Gingivitis (HP:0000230) | 2.62963131 |
| 29 | Prolonged bleeding time (HP:0003010) | 2.62777441 |
| 30 | Purpura (HP:0000979) | 2.62431770 |
| 31 | Pustule (HP:0200039) | 2.61098782 |
| 32 | Premature rupture of membranes (HP:0001788) | 2.57826778 |
| 33 | Metaphyseal cupping (HP:0003021) | 2.57541502 |
| 34 | Lipoatrophy (HP:0100578) | 2.54537669 |
| 35 | Exercise-induced muscle cramps (HP:0003710) | 2.51307036 |
| 36 | Abnormal platelet volume (HP:0011876) | 2.49358399 |
| 37 | Aneurysm (HP:0002617) | 2.49134381 |
| 38 | Ankle contracture (HP:0006466) | 2.48707393 |
| 39 | Gingival bleeding (HP:0000225) | 2.48691109 |
| 40 | Aplasia of the musculature (HP:0100854) | 2.47978027 |
| 41 | Myoglobinuria (HP:0002913) | 2.45538910 |
| 42 | Exercise-induced myalgia (HP:0003738) | 2.45321706 |
| 43 | Bowed forearm bones (HP:0003956) | 2.45318026 |
| 44 | Bowing of the arm (HP:0006488) | 2.45318026 |
| 45 | Male infertility (HP:0003251) | 2.44869233 |
| 46 | Abnormality of the ischium (HP:0003174) | 2.44340795 |
| 47 | Mediastinal lymphadenopathy (HP:0100721) | 2.39511534 |
| 48 | Epistaxis (HP:0000421) | 2.39313525 |
| 49 | Diaphragmatic weakness (HP:0009113) | 2.39104991 |
| 50 | Loss of speech (HP:0002371) | 2.39092755 |
| 51 | Amyloidosis (HP:0011034) | 2.38195987 |
| 52 | Obstructive lung disease (HP:0006536) | 2.37394630 |
| 53 | Chronic obstructive pulmonary disease (HP:0006510) | 2.37394630 |
| 54 | Atrial fibrillation (HP:0005110) | 2.35398888 |
| 55 | Type 1 muscle fiber predominance (HP:0003803) | 2.34332322 |
| 56 | Generalized amyotrophy (HP:0003700) | 2.34086922 |
| 57 | Increased cerebral lipofuscin (HP:0011813) | 2.33923693 |
| 58 | Gastrointestinal infarctions (HP:0005244) | 2.33152709 |
| 59 | Muscle fibrillation (HP:0010546) | 2.33072628 |
| 60 | Vertebral compression fractures (HP:0002953) | 2.29393191 |
| 61 | Interstitial pulmonary disease (HP:0006530) | 2.28873827 |
| 62 | Aortic aneurysm (HP:0004942) | 2.26708233 |
| 63 | Optic neuritis (HP:0100653) | 2.24919652 |
| 64 | Retrobulbar optic neuritis (HP:0100654) | 2.24919652 |
| 65 | Hemorrhage of the eye (HP:0011885) | 2.23483185 |
| 66 | Peritonitis (HP:0002586) | 2.23169589 |
| 67 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.22645849 |
| 68 | Myocardial infarction (HP:0001658) | 2.22515508 |
| 69 | Distal lower limb muscle weakness (HP:0009053) | 2.22496738 |
| 70 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.20854975 |
| 71 | Thin ribs (HP:0000883) | 2.18268510 |
| 72 | Turricephaly (HP:0000262) | 2.17982716 |
| 73 | Increased mean platelet volume (HP:0011877) | 2.17206591 |
| 74 | Difficulty running (HP:0009046) | 2.17197276 |
| 75 | Primary atrial arrhythmia (HP:0001692) | 2.17058230 |
| 76 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.16822076 |
| 77 | Menorrhagia (HP:0000132) | 2.16623248 |
| 78 | Mucopolysacchariduria (HP:0008155) | 2.15100685 |
| 79 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.15100685 |
| 80 | Vertebral hypoplasia (HP:0008417) | 2.14720586 |
| 81 | Aplasia/Hypoplasia of the vertebrae (HP:0008515) | 2.14720586 |
| 82 | Increased IgE level (HP:0003212) | 2.12792054 |
| 83 | Systemic lupus erythematosus (HP:0002725) | 2.12724302 |
| 84 | Upper limb amyotrophy (HP:0009129) | 2.12652419 |
| 85 | Distal upper limb amyotrophy (HP:0007149) | 2.12652419 |
| 86 | Petechiae (HP:0000967) | 2.12619670 |
| 87 | Supraventricular arrhythmia (HP:0005115) | 2.09627652 |
| 88 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 2.09312885 |
| 89 | Urticaria (HP:0001025) | 2.08053480 |
| 90 | Abnormality of the calf musculature (HP:0001430) | 2.07813015 |
| 91 | Subacute progressive viral hepatitis (HP:0006572) | 2.06975897 |
| 92 | Supraventricular tachycardia (HP:0004755) | 2.06283974 |
| 93 | Cerebral inclusion bodies (HP:0100314) | 2.06059204 |
| 94 | Short humerus (HP:0005792) | 2.04231162 |
| 95 | Cervical subluxation (HP:0003308) | 2.02891443 |
| 96 | Bilateral sensorineural hearing impairment (HP:0008619) | 2.02738856 |
| 97 | Rib fusion (HP:0000902) | 2.02446628 |
| 98 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.01426243 |
| 99 | EMG: myopathic abnormalities (HP:0003458) | 2.01123804 |
| 100 | Deep venous thrombosis (HP:0002625) | 2.00811410 |
| 101 | Generalized muscle weakness (HP:0003324) | 1.98047562 |
| 102 | Scapular winging (HP:0003691) | 1.97288299 |
| 103 | Arterial thrombosis (HP:0004420) | 1.96933888 |
| 104 | Recurrent skin infections (HP:0001581) | 1.96500521 |
| 105 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.95882456 |
| 106 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.95882456 |
| 107 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.95882456 |
| 108 | Amniotic constriction ring (HP:0009775) | 1.93693313 |
| 109 | Abnormality of placental membranes (HP:0011409) | 1.93693313 |
| 110 | Joint stiffness (HP:0001387) | 1.93282249 |
| 111 | Neurofibrillary tangles (HP:0002185) | 1.93043851 |
| 112 | Recurrent fungal infections (HP:0002841) | 1.92911363 |
| 113 | Popliteal pterygium (HP:0009756) | 1.92681882 |
| 114 | Dilated cardiomyopathy (HP:0001644) | 1.92049249 |
| 115 | Palpitations (HP:0001962) | 1.91011698 |
| 116 | Osteolytic defects of the hand bones (HP:0009699) | 1.89643236 |
| 117 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.89643236 |
| 118 | Meningitis (HP:0001287) | 1.89357671 |
| 119 | Rhabdomyolysis (HP:0003201) | 1.88929094 |
| 120 | Dysostosis multiplex (HP:0000943) | 1.88726101 |
| 121 | Ventricular arrhythmia (HP:0004308) | 1.88474855 |
| 122 | Broad face (HP:0000283) | 1.88285582 |
| 123 | Gastrointestinal inflammation (HP:0004386) | 1.87968424 |
| 124 | Abnormality of the neuromuscular junction (HP:0003398) | 1.87488263 |
| 125 | Fatigable weakness (HP:0003473) | 1.87488263 |
| 126 | Aplasia/Hypoplasia involving the carpal bones (HP:0006502) | 1.86707622 |
| 127 | Hip contracture (HP:0003273) | 1.86504670 |
| 128 | Congenital hip dislocation (HP:0001374) | 1.85883648 |
| 129 | Spinal rigidity (HP:0003306) | 1.85575676 |
| 130 | Hyperacusis (HP:0010780) | 1.85411836 |
| 131 | Colitis (HP:0002583) | 1.84927902 |
| 132 | Dilatation of the ascending aorta (HP:0005111) | 1.84590971 |
| 133 | Atrioventricular block (HP:0001678) | 1.83686382 |
| 134 | Slow saccadic eye movements (HP:0000514) | 1.83629848 |
| 135 | Limb-girdle muscle atrophy (HP:0003797) | 1.83452779 |
| 136 | Osteomyelitis (HP:0002754) | 1.82788629 |
| 137 | Polygenic inheritance (HP:0010982) | 1.82647937 |
| 138 | Arterial tortuosity (HP:0005116) | 1.81823544 |
| 139 | Vertebral clefting (HP:0008428) | 1.80981410 |
| 140 | Aortic dissection (HP:0002647) | 1.80863717 |
| 141 | Disproportionate tall stature (HP:0001519) | 1.79166858 |
| 142 | Vasculitis (HP:0002633) | 1.79128898 |
| 143 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.79080436 |
| 144 | Distal lower limb amyotrophy (HP:0008944) | 1.78688113 |
| 145 | Ketoacidosis (HP:0001993) | 1.78467213 |
| 146 | Abnormal platelet function (HP:0011869) | 1.77837587 |
| 147 | Impaired platelet aggregation (HP:0003540) | 1.77837587 |
| 148 | Aplasia/hypoplasia of the humerus (HP:0006507) | 1.77626291 |
| 149 | Chest pain (HP:0100749) | 1.77585252 |
| 150 | Esophageal varix (HP:0002040) | 1.77548151 |
| 151 | Abnormality of the peritoneum (HP:0002585) | 1.77427581 |
| 152 | Inflammation of the large intestine (HP:0002037) | 1.77393166 |
| 153 | Broad metatarsal (HP:0001783) | 1.77123017 |
| 154 | Pathologic fracture (HP:0002756) | 1.77011888 |
| 155 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.76926340 |
| 156 | Gowers sign (HP:0003391) | 1.75424962 |
| 157 | Mesangial abnormality (HP:0001966) | 1.75274546 |
| 158 | Ovoid vertebral bodies (HP:0003300) | 1.74040559 |
| 159 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.73828911 |
| 160 | Pterygium (HP:0001059) | 1.73739473 |
| 161 | Upper motor neuron abnormality (HP:0002127) | 1.73626630 |
| 162 | Bundle branch block (HP:0011710) | 1.73014710 |
| 163 | Hepatosplenomegaly (HP:0001433) | 1.71290342 |
| 164 | Abnormal atrioventricular conduction (HP:0005150) | 1.71226715 |
| 165 | Tongue fasciculations (HP:0001308) | 1.71168621 |
| 166 | Bone pain (HP:0002653) | 1.70999514 |
| 167 | Thin bony cortex (HP:0002753) | 1.70906077 |
| 168 | Blue sclerae (HP:0000592) | 1.70744416 |
| 169 | Malnutrition (HP:0004395) | 1.70532431 |
| 170 | Increased variability in muscle fiber diameter (HP:0003557) | 1.70498607 |
| 171 | Abnormality of proline metabolism (HP:0010907) | 1.70226145 |
| 172 | Hydroxyprolinuria (HP:0003080) | 1.70226145 |
| 173 | Aplasia/Hypoplasia involving the musculature (HP:0001460) | 1.69390408 |
| 174 | Axonal loss (HP:0003447) | 1.68830937 |
| 175 | Onion bulb formation (HP:0003383) | 1.68776080 |
| 176 | Gastrointestinal stroma tumor (HP:0100723) | 1.68353716 |
| 177 | Cupped ribs (HP:0000887) | 1.67698676 |
| 178 | Keratoconjunctivitis sicca (HP:0001097) | 1.67637058 |
| 179 | Abnormal hemoglobin (HP:0011902) | 1.67604856 |
| 180 | Vacuolated lymphocytes (HP:0001922) | 1.66596547 |
| 181 | Viral hepatitis (HP:0006562) | 1.65044227 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRIB3 | 3.69787591 |
| 2 | DDR2 | 3.50312787 |
| 3 | RIPK4 | 3.25725330 |
| 4 | ICK | 3.23096618 |
| 5 | TTN | 3.16407877 |
| 6 | PRPF4B | 2.76763647 |
| 7 | PKN2 | 2.64161227 |
| 8 | MAP3K6 | 2.45457573 |
| 9 | LATS1 | 2.44328517 |
| 10 | SMG1 | 2.30814058 |
| 11 | PDGFRA | 2.19060122 |
| 12 | MAP3K11 | 2.16260401 |
| 13 | LATS2 | 2.03089806 |
| 14 | BLK | 1.90149077 |
| 15 | FGFR4 | 1.89654773 |
| 16 | IRAK3 | 1.82318590 |
| 17 | BMX | 1.77104905 |
| 18 | TYK2 | 1.76762158 |
| 19 | PINK1 | 1.76740536 |
| 20 | NEK1 | 1.76714267 |
| 21 | MAP3K13 | 1.76616627 |
| 22 | TRPM7 | 1.76041408 |
| 23 | IRAK4 | 1.74247468 |
| 24 | MAP4K1 | 1.73324317 |
| 25 | ERN1 | 1.69692605 |
| 26 | EPHA2 | 1.69455847 |
| 27 | MAP3K14 | 1.66451095 |
| 28 | STK10 | 1.65061914 |
| 29 | MAPK15 | 1.61517142 |
| 30 | RIPK1 | 1.56404838 |
| 31 | ZAP70 | 1.56039237 |
| 32 | DMPK | 1.51838943 |
| 33 | MAPKAPK3 | 1.51711805 |
| 34 | MATK | 1.51282364 |
| 35 | MAP3K10 | 1.49821692 |
| 36 | STK38L | 1.46481635 |
| 37 | KSR2 | 1.46151140 |
| 38 | EEF2K | 1.42132838 |
| 39 | CDK12 | 1.39807134 |
| 40 | PAK4 | 1.36861365 |
| 41 | MAP3K1 | 1.30119738 |
| 42 | PIM2 | 1.28826398 |
| 43 | TYRO3 | 1.25993366 |
| 44 | CDK6 | 1.25175378 |
| 45 | TBK1 | 1.24161246 |
| 46 | JAK3 | 1.22767041 |
| 47 | MARK2 | 1.18124390 |
| 48 | STK3 | 1.17753169 |
| 49 | TGFBR2 | 1.16573328 |
| 50 | CSK | 1.14822121 |
| 51 | LRRK2 | 1.14657622 |
| 52 | PDK3 | 1.14393054 |
| 53 | PDK4 | 1.14393054 |
| 54 | LMTK2 | 1.13441108 |
| 55 | MAP3K3 | 1.12878898 |
| 56 | SIK1 | 1.12133806 |
| 57 | MOS | 1.11691339 |
| 58 | PRKD2 | 1.10692362 |
| 59 | MTOR | 1.08508808 |
| 60 | GRK6 | 1.07741869 |
| 61 | PDPK1 | 1.07301530 |
| 62 | FES | 1.06983700 |
| 63 | DYRK1B | 1.02502185 |
| 64 | TAOK1 | 1.02496988 |
| 65 | MAP3K2 | 1.00960554 |
| 66 | FGR | 0.98911029 |
| 67 | MAP2K3 | 0.98154572 |
| 68 | JAK1 | 0.96980085 |
| 69 | HCK | 0.96404303 |
| 70 | PTK6 | 0.96361858 |
| 71 | BCKDK | 0.95144365 |
| 72 | RPS6KB2 | 0.93457395 |
| 73 | PTK2 | 0.92087965 |
| 74 | FGFR3 | 0.91837358 |
| 75 | MST1R | 0.90670271 |
| 76 | PDK2 | 0.90590937 |
| 77 | TESK2 | 0.89619988 |
| 78 | FLT3 | 0.88058025 |
| 79 | NEK2 | 0.87858165 |
| 80 | IRAK2 | 0.87226482 |
| 81 | BTK | 0.86614846 |
| 82 | CDK7 | 0.86389770 |
| 83 | PHKG2 | 0.84909660 |
| 84 | PHKG1 | 0.84909660 |
| 85 | JAK2 | 0.83184252 |
| 86 | PIM1 | 0.81935447 |
| 87 | SGK3 | 0.81043526 |
| 88 | MAPK11 | 0.80625852 |
| 89 | YES1 | 0.80083436 |
| 90 | PDK1 | 0.78878437 |
| 91 | TTK | 0.78540688 |
| 92 | TNK2 | 0.76965498 |
| 93 | CSF1R | 0.75795938 |
| 94 | CDC42BPA | 0.75170493 |
| 95 | PAK2 | 0.74511822 |
| 96 | MAP3K8 | 0.74314167 |
| 97 | CAMK1D | 0.74090860 |
| 98 | MYLK | 0.73670233 |
| 99 | RPS6KA2 | 0.73531548 |
| 100 | PRKAA1 | 0.73056160 |
| 101 | PRKAA2 | 0.72921874 |
| 102 | PDGFRB | 0.71373341 |
| 103 | NEK9 | 0.70863180 |
| 104 | RPS6KL1 | 0.68599720 |
| 105 | RPS6KC1 | 0.68599720 |
| 106 | EPHB1 | 0.67904886 |
| 107 | RET | 0.67840348 |
| 108 | IKBKE | 0.66276283 |
| 109 | SIK3 | 0.65118439 |
| 110 | ARAF | 0.63470321 |
| 111 | SYK | 0.63371627 |
| 112 | NME2 | 0.62516849 |
| 113 | RPS6KA6 | 0.62361894 |
| 114 | RPS6KA4 | 0.62182626 |
| 115 | MAP3K7 | 0.59289194 |
| 116 | GSK3A | 0.58449059 |
| 117 | CDK4 | 0.58195603 |
| 118 | PRKD1 | 0.56090842 |
| 119 | LYN | 0.55589451 |
| 120 | SCYL2 | 0.55313749 |
| 121 | STK38 | 0.52497314 |
| 122 | DAPK1 | 0.51547828 |
| 123 | ILK | 0.51198768 |
| 124 | CAMK1G | 0.50411109 |
| 125 | TESK1 | 0.49827989 |
| 126 | IRAK1 | 0.49746831 |
| 127 | PRKG2 | 0.49514714 |
| 128 | TIE1 | 0.49016270 |
| 129 | MAPK12 | 0.47387067 |
| 130 | LCK | 0.46649516 |
| 131 | TAOK3 | 0.44501770 |
| 132 | FYN | 0.43648270 |
| 133 | RPS6KA1 | 0.43259367 |
| 134 | TAOK2 | 0.42984900 |
| 135 | AURKB | 0.42877057 |
| 136 | MAP3K5 | 0.42629381 |
| 137 | HIPK2 | 0.42561244 |
| 138 | KSR1 | 0.40646612 |
| 139 | CDC7 | 0.40359874 |
| 140 | WNK1 | 0.39300585 |
| 141 | PLK1 | 0.38022079 |
| 142 | MAP2K1 | 0.36021858 |
| 143 | AKT2 | 0.35927946 |
| 144 | EGFR | 0.35499710 |
| 145 | MAPKAPK2 | 0.34818537 |
| 146 | FER | 0.33818979 |
| 147 | CHEK2 | 0.33597483 |
| 148 | MET | 0.33204157 |
| 149 | STK4 | 0.33186131 |
| 150 | OBSCN | 0.33006791 |
| 151 | CDK8 | 0.32991742 |
| 152 | STK24 | 0.30591175 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 3.84535400 |
| 2 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.28039313 |
| 3 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 3.05839049 |
| 4 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 2.59030461 |
| 5 | Other glycan degradation_Homo sapiens_hsa00511 | 2.35913035 |
| 6 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.19305300 |
| 7 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 2.06400531 |
| 8 | Leishmaniasis_Homo sapiens_hsa05140 | 2.03218273 |
| 9 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.97128906 |
| 10 | Adherens junction_Homo sapiens_hsa04520 | 1.96342307 |
| 11 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.96176930 |
| 12 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.88487910 |
| 13 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.86573275 |
| 14 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.84387500 |
| 15 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.82793253 |
| 16 | Carbon metabolism_Homo sapiens_hsa01200 | 1.76012270 |
| 17 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.68383062 |
| 18 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.63722962 |
| 19 | Lysine degradation_Homo sapiens_hsa00310 | 1.59982733 |
| 20 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.59342139 |
| 21 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.55701820 |
| 22 | Bladder cancer_Homo sapiens_hsa05219 | 1.54556679 |
| 23 | Focal adhesion_Homo sapiens_hsa04510 | 1.54483506 |
| 24 | Tuberculosis_Homo sapiens_hsa05152 | 1.53217247 |
| 25 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.51243723 |
| 26 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.48244707 |
| 27 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.46958013 |
| 28 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.44764428 |
| 29 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.43351883 |
| 30 | Viral myocarditis_Homo sapiens_hsa05416 | 1.38121371 |
| 31 | Malaria_Homo sapiens_hsa05144 | 1.37675935 |
| 32 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.37025629 |
| 33 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.37008743 |
| 34 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.36237627 |
| 35 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.33072743 |
| 36 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.31600793 |
| 37 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.31366627 |
| 38 | Influenza A_Homo sapiens_hsa05164 | 1.28671839 |
| 39 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.27861459 |
| 40 | Base excision repair_Homo sapiens_hsa03410 | 1.24922129 |
| 41 | Hepatitis C_Homo sapiens_hsa05160 | 1.24432352 |
| 42 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.21642788 |
| 43 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.21011504 |
| 44 | Hippo signaling pathway_Homo sapiens_hsa04390 | 1.20957191 |
| 45 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.20630696 |
| 46 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.16842559 |
| 47 | Endometrial cancer_Homo sapiens_hsa05213 | 1.16658976 |
| 48 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.16576943 |
| 49 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.16512873 |
| 50 | Phagosome_Homo sapiens_hsa04145 | 1.15748252 |
| 51 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.12848463 |
| 52 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.11081611 |
| 53 | Measles_Homo sapiens_hsa05162 | 1.10581764 |
| 54 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.10514926 |
| 55 | Hepatitis B_Homo sapiens_hsa05161 | 1.09877349 |
| 56 | Platelet activation_Homo sapiens_hsa04611 | 1.09220905 |
| 57 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.08017419 |
| 58 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.07454222 |
| 59 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.07152761 |
| 60 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.07097956 |
| 61 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.06909613 |
| 62 | Salmonella infection_Homo sapiens_hsa05132 | 1.04763878 |
| 63 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.04735509 |
| 64 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.01408358 |
| 65 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.01398074 |
| 66 | Endocytosis_Homo sapiens_hsa04144 | 1.00358460 |
| 67 | Tight junction_Homo sapiens_hsa04530 | 1.00031419 |
| 68 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.98660181 |
| 69 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.97829074 |
| 70 | Circadian rhythm_Homo sapiens_hsa04710 | 0.95310706 |
| 71 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.94590656 |
| 72 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.94568536 |
| 73 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.94332822 |
| 74 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.93429573 |
| 75 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.92660367 |
| 76 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.92523817 |
| 77 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.90020792 |
| 78 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.89667664 |
| 79 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.89633690 |
| 80 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.88499158 |
| 81 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.87864660 |
| 82 | Mismatch repair_Homo sapiens_hsa03430 | 0.86952243 |
| 83 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.86561602 |
| 84 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.86409178 |
| 85 | Pertussis_Homo sapiens_hsa05133 | 0.85616675 |
| 86 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.85555635 |
| 87 | Prion diseases_Homo sapiens_hsa05020 | 0.85133985 |
| 88 | Shigellosis_Homo sapiens_hsa05131 | 0.84951687 |
| 89 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.84762127 |
| 90 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.84334612 |
| 91 | Allograft rejection_Homo sapiens_hsa05330 | 0.84123181 |
| 92 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.83690891 |
| 93 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.83661040 |
| 94 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.83470457 |
| 95 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.83452681 |
| 96 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.82591702 |
| 97 | Galactose metabolism_Homo sapiens_hsa00052 | 0.81249623 |
| 98 | Insulin resistance_Homo sapiens_hsa04931 | 0.80861863 |
| 99 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.80156463 |
| 100 | Prostate cancer_Homo sapiens_hsa05215 | 0.79921296 |
| 101 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.77877583 |
| 102 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.77758087 |
| 103 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.77315550 |
| 104 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.77300876 |
| 105 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.77179245 |
| 106 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.76317650 |
| 107 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.76168854 |
| 108 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.75700525 |
| 109 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.75693273 |
| 110 | Cell cycle_Homo sapiens_hsa04110 | 0.75345122 |
| 111 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.75318248 |
| 112 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.75205661 |
| 113 | Amoebiasis_Homo sapiens_hsa05146 | 0.74750986 |
| 114 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.73281687 |
| 115 | DNA replication_Homo sapiens_hsa03030 | 0.73218498 |
| 116 | Glioma_Homo sapiens_hsa05214 | 0.72427138 |
| 117 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.70788127 |
| 118 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.70751577 |
| 119 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.70409418 |
| 120 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.69769165 |
| 121 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.69562714 |
| 122 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.68784413 |
| 123 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.67586109 |
| 124 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.65415602 |
| 125 | Sulfur relay system_Homo sapiens_hsa04122 | 0.65311790 |
| 126 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.63642709 |
| 127 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.62972845 |
| 128 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.62910809 |
| 129 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.62256323 |
| 130 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.62169130 |
| 131 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.62055923 |
| 132 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.61513338 |
| 133 | Colorectal cancer_Homo sapiens_hsa05210 | 0.61203360 |
| 134 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.60809563 |
| 135 | Bile secretion_Homo sapiens_hsa04976 | 0.59926164 |
| 136 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.56634373 |
| 137 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.56232016 |
| 138 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.55540104 |
| 139 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.54376294 |
| 140 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.53989995 |
| 141 | Lysosome_Homo sapiens_hsa04142 | 0.52704084 |
| 142 | Legionellosis_Homo sapiens_hsa05134 | 0.52490246 |
| 143 | Apoptosis_Homo sapiens_hsa04210 | 0.51929455 |
| 144 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.50818142 |
| 145 | Thyroid cancer_Homo sapiens_hsa05216 | 0.50260464 |
| 146 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.49897451 |
| 147 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.48334599 |
| 148 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.48282845 |
| 149 | HTLV-I infection_Homo sapiens_hsa05166 | 0.48156704 |
| 150 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.47251464 |
| 151 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.46532405 |
| 152 | Mineral absorption_Homo sapiens_hsa04978 | 0.46140365 |
| 153 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.46085575 |
| 154 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.44811206 |
| 155 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.44521362 |
| 156 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.44451309 |
| 157 | RNA transport_Homo sapiens_hsa03013 | 0.44279377 |
| 158 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.42826109 |
| 159 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.42480348 |
| 160 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.40617394 |
| 161 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.39584851 |

